Beauty Health Statistics
Share Statistics
Beauty Health has 124.12M shares outstanding. The number of shares has increased by 0.56% in one year.
| Shares Outstanding | 124.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 77.54M |
| Failed to Deliver (FTD) Shares | 811 |
| FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 7.62M, so 6.14% of the outstanding shares have been sold short.
| Short Interest | 7.62M |
| Short % of Shares Out | 6.14% |
| Short % of Float | 9.83% |
| Short Ratio (days to cover) | 10.63 |
Valuation Ratios
The PE ratio is -4.09 and the forward PE ratio is -11.5.
| PE Ratio | -4.09 |
| Forward PE | -11.5 |
| PS Ratio | 1.03 |
| Forward PS | 0.5 |
| PB Ratio | 6.9 |
| P/FCF Ratio | 47.07 |
| PEG Ratio | n/a |
Enterprise Valuation
Beauty Health has an Enterprise Value (EV) of 638.79M.
| EV / Earnings | -6.38 |
| EV / Sales | 1.61 |
| EV / EBITDA | -11.41 |
| EV / EBIT | -4.88 |
| EV / FCF | 73.42 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 12.43.
| Current Ratio | 6.07 |
| Quick Ratio | 5.28 |
| Debt / Equity | 12.43 |
| Total Debt / Capitalization | 92.56 |
| Cash Flow / Debt | 0.03 |
| Interest Coverage | -9.59 |
Financial Efficiency
Return on equity (ROE) is -1.69% and return on capital (ROIC) is -15.85%.
| Return on Equity (ROE) | -1.69% |
| Return on Assets (ROA) | -0.11% |
| Return on Capital (ROIC) | -15.85% |
| Revenue Per Employee | 451.75K |
| Profits Per Employee | -113.64K |
| Employee Count | 881 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.66 |
Taxes
| Income Tax | -1.77M |
| Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -40.22% in the last 52 weeks. The beta is 0.91, so Beauty Health's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | -40.22% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 58.88 |
| Average Volume (20 Days) | 761.22K |
Income Statement
In the last 12 months, Beauty Health had revenue of 397.99M and earned -100.12M in profits. Earnings per share was -0.76.
| Revenue | 397.99M |
| Gross Profit | 155.11M |
| Operating Income | -130.92M |
| Net Income | -100.12M |
| EBITDA | -56.00M |
| EBIT | -130.92M |
| Earnings Per Share (EPS) | -0.76 |
Balance Sheet
The company has 523.02M in cash and 752.29M in debt, giving a net cash position of -229.26M.
| Cash & Cash Equivalents | 523.02M |
| Total Debt | 752.29M |
| Net Cash | -229.26M |
| Retained Earnings | -478.87M |
| Total Assets | 699.55M |
| Working Capital | 411.10M |
Cash Flow
In the last 12 months, operating cash flow was 21.75M and capital expenditures -13.05M, giving a free cash flow of 8.70M.
| Operating Cash Flow | 21.75M |
| Capital Expenditures | -13.05M |
| Free Cash Flow | 8.70M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 3.90K%, with operating and profit margins of -3.29K% and -2.52K%.
| Gross Margin | 3.90K% |
| Operating Margin | -3.29K% |
| Pretax Margin | -2.56K% |
| Profit Margin | -2.52K% |
| EBITDA Margin | -14.07% |
| EBIT Margin | -32.89% |
| FCF Margin | 2.19% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -46.06% |
| FCF Yield | 4.26% |
Analyst Forecast
The average price target for SKIN is $1.88, which is 13.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.88 |
| Price Target Difference | 13.9% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 0.31 |
| Piotroski F-Score | 6 |